undamentalytics Newsletter

Enovix Corp (ENVX) stock

Add holding +

NASDAQ: ENVX Nasdaq Electrical Components & Equipment Next results ~November 12, 2026

D Fundamentals grade

Enovix Corp is a US-listed company in the electrical components & equipment industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: every model's value for Enovix Corp is far from the share price, which usually points to a data problem (a merger, a share-count change, a one-off) rather than a bargain or a bubble.

Price vs value

Under review: free cash flow after stock pay is not positive. We'll show the comparison once resolved.

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders0 buying, 1 selling0 purchases and 1 sale by directors and officers, last 12 monthsInsider trades
  • Funds140 adding, 131 cuttingOf 41 active managers that changed their stake, 22 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Enovix files

Where Enovix stands after its latest 10-Q

Revenue for the twelve months to July 2026 was $36m, up 34.9% on a year earlier, slower than the 49.9% growth a quarter earlier. Free-cash-flow margin rose to -346.2% from -524.6% a year earlier. Operating margin widened to -496.5% from -639.4%. The diluted share count is up 7.2% on a year earlier, which dilutes existing holders. Against its peers on growth, profitability, cash generation and balance sheet, it grades E. It passes 1 of our 6 financial-health checks.

Our model value for Enovix is under review, so past values are not shown until it is resolved.

Source: 10-Q filed August 12, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 12, 2026 (estimated)

Enovix Corp's trailing-twelve-month revenue grew 34.9% year on year, with a free-cash-flow margin of -346.2%. Where it stands out: days sales outstanding of 32 days ranks 9 of 50 electrical components & equipment companies we cover. Where it lags: operating margin of -496.5% ranks 52 of 53 electrical components & equipment companies we cover.

Current signal Free cash flow diverging from earnings: TTM free cash flow grew 11.0% while net income fell 32.8%: a 44pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Strengths

  • Fast growth. Revenue grew 34.9% over the last 12 months, against a median of 10.6% for electrical components & equipment companies we cover.
  • Margins widening. Operating margin is up 142.8 points on a year ago.
  • Beating expectations. Earnings per share beat the analysts' consensus estimate in each of the last four quarters.

Things to watch

  • Growth slowing. The growth rate is 15.0 points lower than a quarter earlier.
  • Loss-making. Operating margin is -496.5%: costs exceed revenue.
  • Burning cash. Free cash flow was -346.2% of revenue over the last 12 months.
  • Heavy stock-based pay. Stock pay equals 133.9% of revenue, against a median of 2.8% for electrical components & equipment companies we cover: a real cost that cash-flow figures leave out.
  • Share dilution. Diluted shares rose 7.2% in a year.
  • High debt. Long-term debt exceeds cash by $0.5bn, more than 1.5 times annual revenue.

Latest results: FY2026 Q2

Filed August 12, 2026
Earnings per share
-$0.13 against an average estimate of -$0.15: beat by 10.9%
Revenue
$9m, up 20.8% on a year earlier
Share reaction
-5.8% in the first session after the results on October 13, 2026, against -1.1% for the S&P 500
Next report
November 12, 2026; average EPS estimate -$0.14

Enovix's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-5.7%
  • 1 week+10.8%
  • 1 month+6.1%
  • This year-59.4%
  • 1 year-75.2%
  • 5 years-90.8%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$35.9M
Operating margin
-496.5%
Net margin
-473.9%
EPS (TTM, diluted)
$-0.79

Growth

Revenue growth
+34.9%
Change in growth rate
−15.0 pts
Share count change
+7.2%

Cash

Free cash flow (TTM)
-$124M
FCF margin
-346.2%
Stock pay % of revenue
133.9%

Earnings

Last results
October 13, 2026
Next results (est.)
December 24, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Announcement
  2. Announcement
  3. Results
  4. Leadership
  5. Results
  6. Leadership

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: free cash flow after stock pay is not positive.

The inputs used by the models below have passed source checks. Individual model values are available below and in the interactive valuator. Their differences are shown explicitly; the platform combined value and recommendation remain withheld.

Valuation models

We value Enovix Corp as an operating company, with every model that fits that kind of business. Cost of equity 13.4%: the 10-year Treasury yield (4.9%) plus a beta of 1.89 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Growth cash-flow model Revenue for this year and next from analysts' consensus, then growth fading to 2.5%; the operating margin moving to profitable peers'; investment needed per dollar of growth from peers; reduced by a failure probability. For young or fast-growing companies. The starting margin is normalized to between -100% and 60%; net margin is a proxy when operating income is not tagged. Uses analysts' consensus estimates (third-party data), not our forecasts. — Does not apply: the projected cash flows don't support a positive value
Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. — Does not apply: This model is withheld pending its input or assumption review.
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: This model is withheld pending its input or assumption review.
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: This model is withheld pending its input or assumption review.
Forward price-to-sales vs peers Next year's consensus sales per share times peers' typical forward price-to-sales; only when earnings are negative. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$0.4 ~$0.4–$1.3 Left out: out of range vs price (0.14x)
Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. — Does not apply: This model is withheld pending its input or assumption review.
Combined value Individual source-checked model scenarios are available. The platform combined value and recommendation remain withheld. — Combined value withheld. Review the individual models and their assumptions.

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Enovix Corp with Electrical Components & Equipment in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

Enovix Corp: market value and multiples by fiscal year
At fiscal year end 20212022202320242025Now
Share price$27.28$12.44$12.52$11.28$7.63$2.97
Market value$3.2bn$1.9bn$2.1bn$2.1bn$1.6bn$637m
+ Net debt (− = net cash)−$385m−$323m−$57m−$94m$427m$499m
Enterprise value$2.8bn$1.6bn$2.1bn$2.0bn$2.0bn$1.1bn
Multiples
Price / sales —n/mn/m90.9x49.8x17.8x
Price / earnings ——————
Price / free cash flow ——————
EV / EBITDA ——————

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

12 /100

Weak moat

How hard Enovix's competitive advantage looks for rivals to wear away, judged from 6 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Net income has been a median -26.1% of total assets over 6 years.

  • Pricing power 0 / 20

    Gross margin has been a median -27.0%, moving by 1437.0 percentage points (standard deviation) across 5 years.

  • Durability 10 / 20

    Operating margin has been a median -1648.8%; its worst year was -16660.5%.

  • Cash conversion 0 / 20

    Free cash flow was positive in 0 of 5 years, at a median -1226.4% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 12, 2026, before the open. Analysts expect revenue of $10m and EPS of −$0.14 (range −$0.15 to −$0.13) for the quarter.

Analysts' consensus

Enovix Corp: consensus estimates
Fiscal yearEPSGrowthRevenueGrowth
Current −$0.56 −4% $39m +23%
Next −$0.63 −12% $76m +93%

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is −0.3% on 90 days ago. In the last 30 days, 5 analysts raised Enovix Corp's forecast and 4 cut it.

Consensus EPS forecast Enovix Corp, last 90 days
−$0.80 −$0.60 −$0.40 −$0.20 $0.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: −$0.56 Current fiscal year, 60 days ago: −$0.57 Current fiscal year, 30 days ago: −$0.57 Current fiscal year, 7 days ago: −$0.55 Current fiscal year, Now: −$0.56 −$0.56 Next fiscal year, 90 days ago: −$0.57 Next fiscal year, 60 days ago: −$0.63 Next fiscal year, 30 days ago: −$0.63 Next fiscal year, 7 days ago: −$0.63 Next fiscal year, Now: −$0.63 −$0.63

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago −$0.56−$0.57
60 days ago −$0.57−$0.63
30 days ago −$0.57−$0.63
7 days ago −$0.55−$0.63
Now −$0.56−$0.63

Earnings against estimates

Enovix Corp: reported EPS against the consensus estimate
Quarter toEstimateActualSurprise
Jun 2026 −$0.15 −$0.13 +10.9%
Mar 2026 −$0.15 −$0.14 +7.1%
Dec 2025 −$0.17 −$0.14 +19.6%
Sept 2025 −$0.16 −$0.14 +10.7%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, October 13, 2026

No numeric guidance in Enovix Corp's latest earnings release (filed October 13, 2026). Some companies give their outlook only on the earnings call.

Analyst recommendations

12 analysts, Oct 2026
Buy867%
Hold325%
Sell18%

Monthly trend

  1. Oct 202683112
  2. Sep 202683112
  3. Aug 202692112

Counts of recommendations published by analysts covering Enovix Corp, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
29.3%
of tradable shares
Days to cover
7.04
at average volume
Short interest, 1 month
+9%
to October 15, 2026
Held by institutions
52%
of shares
Held by insiders
11.7%
of shares
Employees
664
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months −75.2%

$11.99 on October 31, 2025 to $2.97

Enovix Corp: share-price change split into its parts
PartThenNowEffect
Revenue (last 12 months) $27m $36m +34.9%
P/S multiple 90.3x 17.8x −80.3%
Share count 200m 215m −6.7%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

Last 3 years −72.0%

$10.59 on November 3, 2023 to $2.97

Enovix Corp: share-price change split into its parts
PartThenNowEffect
Revenue (last 12 months) $1m $36m +2982.4%
P/S multiple n/m 17.8x −98.7%
Share count 156m 215m −27.4%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Enovix Corp: yearly return, monthly win rate and worst fall against the S&P 500
Calendar year 20222023202420252026 to date
Return
ENVX−54%+1%−13%−33%−59%
Industry peers (median)−30%−18%−7%+14%−35%
S&P 500−18%+26%+25%+18%+11%
Months that ended higher
ENVX42%58%42%50%27%
S&P 50042%67%75%75%46%
Largest fall from a high during the year
ENVX−73%−61%−59%−62%−74%
S&P 500−25%−10%−8%−19%−9%

Worst fall since January 5, 2021: 94% from November 19, 2021 to October 20, 2026. Getting back needed a 1492% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$2.25 – $12.21
From 52-week high
−75.7%
vs 50-day average
+0.8%
vs 200-day average
−42.1%
Volatility (1 year)
91%
Beta vs S&P 500
3.70

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
2 up, 10 down
typical move ±10.8%
After a week
1 up, 11 down
typical move ±18.1%
After a month
1 up, 10 down
typical move ±20.4%
Enovix Corp: share-price change after each results release
Results releasedNext dayS&P 500 next day5 days21 days
October 13, 2026 −5.8% −1.1% −13.1% —
August 12, 2026 −8.3% +0.9% −29.6% −35.8%
May 13, 2026 −9.6% +1.4% −8.8% −4.4%
February 25, 2026 −2.6% +0.3% −16.4% −16.2%
January 20, 2026 −8.7% −0.9% −12.4% −26.8%
November 5, 2025 −18.7% −0.7% −24.8% −19.4%
July 31, 2025 −20.7% −2.0% −18.5% −28.7%
July 7, 2025 +18.0% −0.8% +28.6% −1.1%
April 30, 2025 −9.3% +0.7% −8.7% +12.6%
February 19, 2025 +2.8% −0.2% −13.7% −28.7%
October 29, 2024 −8.2% −0.1% −19.9% −19.1%
July 31, 2024 −17.4% +0.2% −22.9% −31.4%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Enovix Corp in five measures

Fundamentals grade D
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Enovix Corp
$0 $10M $20M $30M $40M FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $1.4M Revenue (TTM), FY23 Q4: $7.6M Revenue (TTM), FY24 Q1: $12.9M Revenue (TTM), FY24 Q2: $16.6M Revenue (TTM), FY24 Q3: $20.7M Revenue (TTM), FY24 Q4: $23.1M Revenue (TTM), FY25 Q1: $22.9M Revenue (TTM), FY25 Q2: $26.6M Revenue (TTM), FY25 Q3: $30.3M Revenue (TTM), FY25 Q4: $31.8M Revenue (TTM), FY26 Q1: $34.3M Revenue (TTM), FY26 Q2: $35.9M $35.9M

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $1.4M
FY23 Q4 $7.6M
FY24 Q1 $12.9M
FY24 Q2 $16.6M
FY24 Q3 $20.7M
FY24 Q4 $23.1M
FY25 Q1 $22.9M
FY25 Q2 $26.6M
FY25 Q3 $30.3M
FY25 Q4 $31.8M
FY26 Q1 $34.3M
FY26 Q2 $35.9M
Revenue growth, TTM YoY Enovix Corp
-500% 0% 500% 1000% 1500% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: -73.5% Revenue growth, TTM YoY, FY23 Q4: 23.3% Revenue growth, TTM YoY, FY24 Q1: 107.2% Revenue growth, TTM YoY, FY24 Q2: 1327.9% Revenue growth, TTM YoY, FY24 Q3: 1429.4% Revenue growth, TTM YoY, FY24 Q4: 201.9% Revenue growth, TTM YoY, FY25 Q1: 77.6% Revenue growth, TTM YoY, FY25 Q2: 60.0% Revenue growth, TTM YoY, FY25 Q3: 46.0% Revenue growth, TTM YoY, FY25 Q4: 37.9% Revenue growth, TTM YoY, FY26 Q1: 49.9% Revenue growth, TTM YoY, FY26 Q2: 34.9% 34.9%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 -73.5%
FY23 Q4 23.3%
FY24 Q1 107.2%
FY24 Q2 1327.9%
FY24 Q3 1429.4%
FY24 Q4 201.9%
FY25 Q1 77.6%
FY25 Q2 60.0%
FY25 Q3 46.0%
FY25 Q4 37.9%
FY26 Q1 49.9%
FY26 Q2 34.9%
Operating margin (TTM) Enovix Corp
-20000% -15000% -10000% -5000% 0% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Operating margin (TTM), FY23 Q3: -15533.3% Operating margin (TTM), FY23 Q4: -3012.2% Operating margin (TTM), FY24 Q1: -1839.0% Operating margin (TTM), FY24 Q2: -1648.8% Operating margin (TTM), FY24 Q3: -1316.1% Operating margin (TTM), FY24 Q4: -1051.7% Operating margin (TTM), FY25 Q1: -939.3% Operating margin (TTM), FY25 Q2: -639.4% Operating margin (TTM), FY25 Q3: -554.2% Operating margin (TTM), FY25 Q4: -557.0% Operating margin (TTM), FY26 Q1: -520.3% Operating margin (TTM), FY26 Q2: -496.5% -496.5%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q3 -15533.3%
FY23 Q4 -3012.2%
FY24 Q1 -1839.0%
FY24 Q2 -1648.8%
FY24 Q3 -1316.1%
FY24 Q4 -1051.7%
FY25 Q1 -939.3%
FY25 Q2 -639.4%
FY25 Q3 -554.2%
FY25 Q4 -557.0%
FY26 Q1 -520.3%
FY26 Q2 -496.5%
FCF margin (TTM) Enovix Corp
-15000% -10000% -5000% 0% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: -10108.4% FCF margin (TTM), FY23 Q4: -2177.3% FCF margin (TTM), FY24 Q1: -1457.3% FCF margin (TTM), FY24 Q2: -1226.4% FCF margin (TTM), FY24 Q3: -1005.6% FCF margin (TTM), FY24 Q4: -801.0% FCF margin (TTM), FY25 Q1: -689.4% FCF margin (TTM), FY25 Q2: -524.6% FCF margin (TTM), FY25 Q3: -389.2% FCF margin (TTM), FY25 Q4: -356.7% FCF margin (TTM), FY26 Q1: -368.9% FCF margin (TTM), FY26 Q2: -346.2% -346.2%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 -10108.4%
FY23 Q4 -2177.3%
FY24 Q1 -1457.3%
FY24 Q2 -1226.4%
FY24 Q3 -1005.6%
FY24 Q4 -801.0%
FY25 Q1 -689.4%
FY25 Q2 -524.6%
FY25 Q3 -389.2%
FY25 Q4 -356.7%
FY26 Q1 -368.9%
FY26 Q2 -346.2%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Enovix Corp: annual financial statements
Fiscal year 2020 Dec 2020 2021 Jan 2022 2022 Jan 2023 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jul 2026
Income
Revenue 0 0 6 8 23 32 36
Gross profit −3 −2 −17 −55 −2 6 7
EBITDA −23 −68 −124 −196 −198 −142 −143
Operating income −24 −70 −132 −230 −243 −177 −178
Net income −40 −126 −52 −214 −222 −157 −170
Diluted EPS −$0.49 −$1.07 −$0.82 −$1.30 −$1.19 −$0.75 −$0.79
Growth (year on year)
Revenue — — — +23.3% +201.9% +37.9% +34.9%
Margins
Gross margin — — −274.7% −725.0% −8.9% 19.2% 18.8%
EBITDA margin — — <−999% <−999% −856.8% −446.7% −397.5%
Operating margin — — <−999% <−999% <−999% −557.0% −496.5%
Net margin — — −832.3% <−999% −963.2% −492.6% −473.9%
Free-cash-flow margin — — <−999% <−999% −801.0% −356.7% −346.2%
Cash flow
Cash from operations −20 −51 −83 −105 −109 −95 −107
Capital spending 27 44 36 62 76 18 17
Free cash flow −47 −95 −119 −166 −185 −114 −124
Stock-based pay 1 11 30 69 59 49 48
Free cash flow after stock pay −48 −106 −149 −236 −244 −163 −172
Balance sheet
Cash 29 385 323 233 273 106 34
Total debt 0 0 0 176 179 533 533
Net debt (negative = net cash) −29 −385 −323 −57 −94 427 499
Diluted shares 80m 117m 154m 170m 186m 208m 215m
Returned to shareholders
Buybacks 0 0 0 0 0 58 —
Total returned 0 0 0 0 0 58 —

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

1 of 6 checks passed · July 5, 2026
What it owns · $800m
Short-term assets $506mLonger-term assets $294m
What it owes, and who funded it · $798m
Short-term liabilities $52mLonger-term liabilities $536mShareholders' equity $210m
  • Short-term assets cover short-term liabilities $506m of assets due within a year against $52m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $506m short-term assets against $536m of longer-dated liabilities.
  • More cash than debt $34m of cash against $532m of debt.
  • Debt below 40% of shareholders' equity Debt is 253% of equity.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt −$107m of operating cash flow against $532m of debt.
  • Operating profit covers interest at least five times over Operating income of −$178m against $32m of interest.

From Enovix Corp's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Buybacks, last 3 fiscal years
$58.4M
Diluted share count
+7.2%
year over year
R&D spending
298.9%
of revenue
Sales & admin spending
216.5%
of revenue
Days sales outstanding
32 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in electrical components & equipment
Growth, margins and cash generation against peers
Last 12 months unless stated ENVX FLUX EPOW BEEM XCH DFLI Median
Revenue, last 12 months $36m $42m $46m $27m $25m $52m $154m
Revenue growth, last 12 months 34.9% −36.6% −28.6% −20.5% −40.5% −4.9% 10.6%
Revenue growth, 3-year average 213.5% −14.1% — −23.6% — −15.0% 9.2%
Revenue growth, latest quarter 20.8% −50.7% — 21.0% — −19.0% 10.2%
Gross margin 18.8% 30.2% −12.6% 10.2% 46.2% 25.4% 29.3%
Operating margin −496.5% −15.4% −34.5% −64.9% −129.9% −43.6% −17.7%
Operating margin, 3-year average −928.2% −11.3% — −53.9% — −42.0% −32.6%
Net margin −473.9% −17.7% −35.8% −64.6% −129.5% −129.4% −23.4%
Cash from operations / revenue −299.3% −14.0% −54.2% −49.6% −30.0% −55.4% −6.5%
Free-cash-flow margin −346.2% −15.3% −68.0% −48.9% −31.1% −57.3% −11.0%
Free-cash-flow margin, 3-year average −699.0% −8.2% — −26.5% — −41.7% −6.8%
Stock pay / revenue 133.9% 2.3% 0.7% 4.4% 83.4% 1.7% 2.5%
Change in share count 7.2% 18.6% 10.0% −99.6% 117.3% — 10.0%

Median of all 57 companies we cover in electrical components & equipment. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

57 electrical components & equipment companies
Measures ranked against peers
Measure Company Peer median Rank
Revenue growth Growth 34.9% 10.6% 18 of 57
Change in growth rate Growth -15.0pp +0.0pp 43 of 57
Gross margin Profitability 18.8% 29.3% 36 of 54
Operating margin Profitability -496.5% -20.0% 52 of 53
Net margin Profitability -473.9% -23.4% 55 of 57
Free-cash-flow margin Cash generation -346.2% -8.8% 54 of 56
Stock pay as % of revenue Cash generation 133.9% 2.8% 48 of 50
Long-term debt as % of assets Balance sheet 65.2% 17.8% 39 of 40
Change in share count Balance sheet 7.2% 10.0% 22 of 46
Days sales outstanding Balance sheet 32 days 72 days 9 of 50

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 28, 2025
Geography
Region Revenue Share YoY
Asia Pacific $21.6M 68.0% ▲ 67.7%
Switzerland $4.3M 13.6% ▼ 9.3%
United States $2.1M 6.7% ▲ 138.5%
NO $1.5M 4.8% ▼ 34.8%
Other $1.2M 3.7% ▼ 6.0%
Taiwan $1M 3.2% ▲ 15.0%

From Enovix Corp's 10-K filed February 25, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Reported value
$674M
Institutions reporting
297
Shares held vs prior quarter
▲ 2.4%
Positions opened / closed
29 / 35

Top buyers and sellers, Q2 2026: 140 institutions bought and 131 sold ; the biggest buyer was Morgan Stanley (+1.7M shares) and the biggest seller Millennium Management LLC (−1.6M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $100M 16.5M 14.8% ▲ 7.5%
Vanguard Capital Management LLC $51.6M 8.5M 7.7% ▲ 1.4%
Vanguard Portfolio Management LLC $50.8M 8.4M 7.5% ▲ 4.0%
UBS Group AG $32.2M 5.3M 4.8% ▼ 8.0%
Geode Capital Management, LLC $31.5M 5.2M 4.7% ▲ 6.4%
Electron Capital Partners, LLC $29.1M 4.8M 4.3% ▲ 3.5%
State Street Corp $28.7M 4.7M 4.3% ▲ 9.4%
Morgan Stanley $21.1M 3.5M 3.1% ▲ 91.5%
Royal Bank Of Canada $15.2M 2.5M 2.3% ▲ 0.5%
Fred Alger Management, LLC $12.7M 2.1M 1.9% ▲ 6.3%
Susquehanna International Group, LLP $12.7M 2.1M 1.9% ▲ 15.7%
Centerbook Partners LP $12.4M 2.0M 1.8% ▼ 30.6%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Enovix Corp's complete shareholder register. Values are as reported by the filers ; 1 inconsistently scaled filing rows were excluded.

Insider trading activity

Full insider history and chart
Recent insider open-market transactions
Insider Date Trade Shares Price Value
Truong Kristina Chief Accounting Officer January 1, 2026 Sell 2,296 $7.31 $16,784

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 1 trade and filings

No trades in Enovix Corp disclosed in the last 12 months; 1 earlier trade on record.

  • Daniel S. Goldman(D-NY 10):Sale (full), $1,001 - $15,000, traded January 31, 2023, filed February 24, 2023

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around December 24, 2026 estimated from the company's past filing pattern, not announced

  • October 13, 2026
  • August 12, 2026
  • May 13, 2026
  • February 25, 2026
  • January 20, 2026
  • November 5, 2025

Recent SEC filings

Data status

When each part of this page on Enovix Corp was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Enovix Corp in brief

What does Enovix Corp do?
Enovix Corp is a US-listed company in the electrical components & equipment industry. Its financial year ends in December.
What is Enovix Corp's stock ticker?
Enovix Corp trades under the ticker ENVX on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Enovix Corp's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Enovix Corp reported revenue of $35.9M, 34.9% higher than a year earlier, according to its SEC filings.
What is Enovix Corp's free cash flow?
Enovix Corp's free-cash-flow margin is -346.2% of revenue over the trailing twelve months, ranking 54 of the 56 electrical components & equipment companies we cover.
Who are Enovix Corp's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., Vanguard Capital Management LLC and Vanguard Portfolio Management LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Enovix Corp's market cap?
On November 2, 2026, Enovix Corp's market capitalisation was about $637M and net debt of $499M. Market figures come from third-party market data and may be delayed.
How much debt does Enovix Corp have?
Enovix Corp's debt-to-equity ratio is 253.2%, from its latest balance sheet. The financial health section below sets out its other solvency checks.
Who are Enovix Corp's competitors?
In our Electrical Components & Equipment peer group, the companies closest to Enovix Corp are Flux Power Holdings, Inc., E-power Inc., Beam Global, Xchg Ltd and Dragonfly Energy Holdings Corp. The side-by-side comparison below sets their revenue, margins and growth against Enovix Corp's.
Are insiders buying or selling Enovix Corp stock?
Over the last 12 months, Enovix Corp's directors and officers reported 0 open-market purchases and 1 sales on Form 4. The insider trading page charts every trade.
When is Enovix Corp's next earnings date?
Around November 12, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Enovix Corp announces its own schedule.